We are live on ! Find out more
ICM

ISZO Capital Management Portfolio holdings

AUM $2M
1-Year Est. Return 35.61%
This Fund
S&P 500
This Quarter Est. Return
+24.95%
1 Year Est. Return
+35.61%
3 Year Est. Return
+68.24%
5 Year Est. Return
+471.73%
10 Year Est. Return
–
AUM
$18.8M
AUM Growth
+$11.3M
Cap. Flow
+$14.6M
Cap. Flow %
77.41%
Top 10 Hldgs %
100%
Holding
14
New
7
Increased
1
Reduced
–
Closed
4

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$5.35M
2
FRC
First Republic Bank
FRC
+$5.33M
3
UTHR icon
United Therapeutics
UTHR
+$2.22M
4
NVS icon
Novartis
NVS
+$1.92M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$1.42M

Top Sells

Rank Stock Value
1
LFCR icon
Lifecore Biomedical
LFCR
+$2.42M
2
CBL
CBL Properties
CBL
+$1.81M
3
CCEL icon
Cryo-Cell International
CCEL
+$825K
4
CVNA icon
Carvana
CVNA
+$711K

Sector Composition

Rank Sector Weight
1 Healthcare 71.28%
2 Energy 0.03%
3 Consumer Discretionary 0%
4 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LNTH icon
1
Lantheus
LNTH
$6.49B
$8.26M 43.89%
100,000
+82,923
+486% +$5.35M
NVS icon
2
Novartis
NVS
$297B
$2.02M 10.76%
+22,000
New +$1.92M
UTHR icon
3
United Therapeutics
UTHR
$25.8B
$2.02M 10.71%
+9,000
New +$2.22M
QQQ icon
4
Invesco QQQ Trust
QQQ
$453B
$1.54M 8.19%
+4,800
New +$1.42M
NVO
5
Novo Nordisk
NVO
$208B
$1.11M 5.92%
+14,000
New +$993K
SPY icon
6
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$1.02M 5.44%
+2,500
New +$997K
FRC
7
DELISTED
First Republic Bank
FRC
$727K 3.87%
+52,000
New +$5.33M
AMPY icon
8
Amplify Energy
AMPY
$161M
$6.55K 0.03%
953
– –
CBL
9
CBL Properties
CBL
$1.82B
– –
-78,316
Closed -$1.81M
CCEL icon
10
Cryo-Cell International
CCEL
$27.6M
– –
-195,031
Closed -$825K
CVNA icon
11
Carvana
CVNA
$68.6B
– –
-750,000
Closed -$711K
LFCR icon
12
Lifecore Biomedical
LFCR
$166M
– –
-373,778
Closed -$2.42M
CO
13
DELISTED
Global Cord Blood Corporation
CO
$0 ﹤0.01%
279,495
– –

Similar funds

LBC
Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
STC
Sarah T. Connolly $1.11M AUM 24.13% 1-Year Est. Return
GC
Gilfoyle & Co San Francisco, California $671K AUM
DU
Delphia (USA) Toronto, Ontario, Canada $445K AUM 28.82% 1-Year Est. Return

ISZO Capital Management's Q1 2023 Portfolio in Review

As of Q1 2023, ISZO Capital Management held 14 positions worth $18.8M, up 152% from $7.48M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ISZO Capital Management deployed $14.6M of net new capital in Q1 2023, opening 7 new positions and adding to 1 existing holding. Its largest new stake was First Republic Bank: 52,000 shares worth $727K.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, up from 55% a quarter earlier, followed by Energy and Consumer Discretionary.

On the sell side, the most notable exit was Lifecore Biomedical, an estimated $2.42M sold.

  • ISZO Capital Management's largest Q1 2023 buy was First Republic Bank: 52,000 shares worth $727K.
  • ISZO Capital Management added most to Lantheus in Q1 2023, an estimated $5.35M increase.
  • ISZO Capital Management fully exited Lifecore Biomedical in Q1 2023, selling an estimated $2.42M.
  • ISZO Capital Management's ten largest holdings make up 100% of its $18.8M portfolio in Q1 2023.
  • ISZO Capital Management opened 7 new positions and closed 4 in Q1 2023.
  • ISZO Capital Management's portfolio value rose 152% quarter-over-quarter to $18.8M.

Based on ISZO Capital Management's 13F filing for Q1 2023, filed 15 May 2023.